An abstract is not available for this product.
An abstract is not available for this product.
Complements (A) at.
«Hide
from
Richard G. Hamermesh,
Brian J. Delacey
Source: Harvard Business School
1 pages.
Release date: 30 January 2006. Prod #: 806 081 PDF-ENG
Endo Pharmaceuticals (S): Judge Rules stone HBR case solution
[related_post themes="flat"]
Related Case Solutions
Endo Pharmaceuticals (D): Hatch-Waxman Change- Endo Pharmaceuticals (B): Merger Decision
- Quality Imaging Products (QIP)
- Vertex Pharmaceuticals: R&D Portfolio Management (B)
- Vertex Pharmaceuticals: R&D Portfolio Management (C)
- First National Bank Corp. (B)
- Golden Rule
- Growth at Stein Bodello & Associates Inc.
- Endo Pharmaceuticals (F): Appeals Court Ruling
- Endo Pharmaceuticals (C): An At Risk Launch